Nektar Therapeutics (NKTR)

70.70 -1.75 (-2.42%) USD  |  NASDAQ  |  Mar 06, 16:00
70.59 -0.11 (-0.16%) After-Hours: 20:00
More

Nektar Therapeutics Allow for Loan/Lease Loss (Quarterly)

Allow for Loan/Lease Loss (Quarterly) Chart

View Allow for Loan/Lease Loss (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Allow for Loan/Lease Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years

View Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Allow for Loan/Lease Loss (Quarterly) Benchmarks

View Allow for Loan/Lease Loss (Quarterly) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. --
Insmed, Inc. --
Regeneron Pharmaceuticals, Inc. --
Ironwood Pharmaceuticals, Inc. --
Lyell Immunopharma, Inc. --